Results 191 to 200 of about 18,422 (295)

Reframing Justice in Healthcare AI: An Ubuntu‐Based Approach for Africa

open access: yesDeveloping World Bioethics, EarlyView.
ABSTRACT There is an ongoing debate on how to balance the benefits and risks of artificial intelligence (AI), especially in healthcare. In resource‐constrained settings, such as Africa, where access to quality care remains a challenge, AI has the potential to improve efficiency, accessibility, and patient outcomes.
Aloysius Ochasi   +3 more
wiley   +1 more source

Cost‐effectiveness of investing in earlier access to diabetic foot services: A multi‐centre pre‐post study

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims We evaluated the cost‐effectiveness of implementing a novel funding model to incentivise earlier access of patients with diabetes‐related foot disease (DFD) to diabetic foot services (DFS). Methods In this multi‐centre pre‐post study, we compared the cost, quality‐adjusted life year (QALY) and clinical outcomes of patients with diabetes ...
Son Nghiem   +10 more
wiley   +1 more source

Cost‐Effectiveness of NT‐proBNP–Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real‐World Evidence From the Hong Kong Diabetes Biobank

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Heart failure (HF) is among the most costly and prevalent complications of type 2 diabetes (T2D), with annual incremental healthcare costs reaching US$12800 in Hong Kong. We evaluated the cost‐effectiveness of NT‐proBNP‐guided cardiovascular risk stratification to guide cardioprotective treatment. Materials and Methods We developed a four‐
Abby Q. Y. Li   +6 more
wiley   +1 more source

A Patient-Specific Winston-Lutz System for Multi-Target Single Isocentre Radiotherapy

open access: yes
This work introduces a novel quality assurance (QA) system for verifying patient-specific radiation targeting accuracy in multi-target, single-isocentre, stereotactic radiosurgery (SRS).
Schenkels, Kassia
core  

Cost‐Effectiveness of Pharmacologic Therapies for Metabolic Dysfunction–Associated Steatohepatitis With Significant Fibrosis in the United States

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The approval of new pharmacotherapies for metabolic dysfunction‐associated steatohepatitis (MASH) presents a critical need for value assessment. We evaluated the cost‐effectiveness of resmetirom, semaglutide and tirzepatide for U.S. adults with MASH and F2–F3 fibrosis.
Ali A. Abdeen   +5 more
wiley   +1 more source

From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT The integration of measurable residual disease (MRD) into the management of chronic lymphocytic leukemia (CLL) has emerged as a major advance in risk stratification and trial design, particularly in the context of time‐limited, targeted regimens.
Enrica Antonia Martino   +13 more
wiley   +1 more source

Potential Role of Liver Transplantation for Child–Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan—A Retrospective Single‐Center Study

open access: yesHepatology Research, EarlyView.
Among patients with CP‐A HCC initially within the Japan criteria, some lose oncological eligibility for LT before hepatic decompensation. Further studies are needed to identify baseline factors associated with poor outcomes and to evaluate their relevance to future LT candidacy.
Akihiro Seki   +16 more
wiley   +1 more source

Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Lymphomas remain among the most frequent HIV‐associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics of lymphomas (both Hodgkin [HL] and non‐Hodgkin [NHL]) in people living with HIV (PLWH), according to virological ...
Teresa Aldámiz‐Echevarria   +555 more
wiley   +1 more source

A prospective study of 12‐month survival of patients with cirrhosis admitted to intensive care

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background The assessment on whether to escalate care in patients with cirrhosis to the intensive care unit (ICU) is complex, with little data on long‐term outcomes. The primary aim of this study was to prospectively examine the ability of liver‐specific and ICU prognostic scores to predict 12‐month survival among patients with cirrhosis in ...
Minnie Au   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy